| Winner Regional Healthcare Center | |
| 805 E 8th St, Winner, South Dakota 57580 | |
| (605) 842-7200 | |
| Name | Winner Regional Healthcare Center |
|---|---|
| Location | 805 E 8th St, Winner, South Dakota |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 33 |
| Occupancy Rate | 108.18% |
| Medicare ID (CCN) | 435056 |
| Legal Business Name | Winner Regional Healthcare Center |
| Ownership Type | Non Profit - Corporation |
| NPI Number | 1568538478 |
| Organization Name | WINNER REGIONAL HEALTHCARE CENTER |
| Address | 745 E 8th St, Winner, SD 57580 |
| Phone Number | 605-842-7100 |
News Archive
Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs and companion diagnostics, today announced the treatment of its first patient in a multicentre, open, non-comparative Phase III study to investigate the efficacy, safety, and pharmacokinetics of two subcutaneous (SC) injections of Debio 8206 (triptorelin pamoate 22.5 mg 6-month formulation) in patients with advanced prostate cancer.
For adults, the goal of exercise is often to shed some pounds, but new research from the University of Georgia suggests the objective should be different for kids.
Many experts believe a milestone has been reached with the issuing of guidelines for pharmaceutical companies to encourage them to gather and submit information about how genetic variations affect the way people respond to their drugs.
HMS Holdings Corp. today announced its financial results for the third quarter of 2009.
Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal 510(k) clearance to market a new software release for its Autopheresis-C® system. Blood and plasma centers worldwide use the Autopheresis-C system to collect plasma from donors.
› Verified 5 days ago
| NPI Number | 1659447563 |
| Organization Name | WINNER REGIONAL HEALTHCARE CENTER |
| Address | 745 E 8th St, Winner, SD 57580 |
| Phone Number | 605-842-7100 |
News Archive
Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs and companion diagnostics, today announced the treatment of its first patient in a multicentre, open, non-comparative Phase III study to investigate the efficacy, safety, and pharmacokinetics of two subcutaneous (SC) injections of Debio 8206 (triptorelin pamoate 22.5 mg 6-month formulation) in patients with advanced prostate cancer.
For adults, the goal of exercise is often to shed some pounds, but new research from the University of Georgia suggests the objective should be different for kids.
Many experts believe a milestone has been reached with the issuing of guidelines for pharmaceutical companies to encourage them to gather and submit information about how genetic variations affect the way people respond to their drugs.
HMS Holdings Corp. today announced its financial results for the third quarter of 2009.
Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal 510(k) clearance to market a new software release for its Autopheresis-C® system. Blood and plasma centers worldwide use the Autopheresis-C system to collect plasma from donors.
› Verified 5 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs and companion diagnostics, today announced the treatment of its first patient in a multicentre, open, non-comparative Phase III study to investigate the efficacy, safety, and pharmacokinetics of two subcutaneous (SC) injections of Debio 8206 (triptorelin pamoate 22.5 mg 6-month formulation) in patients with advanced prostate cancer.
For adults, the goal of exercise is often to shed some pounds, but new research from the University of Georgia suggests the objective should be different for kids.
Many experts believe a milestone has been reached with the issuing of guidelines for pharmaceutical companies to encourage them to gather and submit information about how genetic variations affect the way people respond to their drugs.
HMS Holdings Corp. today announced its financial results for the third quarter of 2009.
Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal 510(k) clearance to market a new software release for its Autopheresis-C® system. Blood and plasma centers worldwide use the Autopheresis-C system to collect plasma from donors.
› Verified 5 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $3250 |
| Number of Payment Denials | 1 |
| Total Number of Penalties | 2 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 19.85 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 16.44 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 52.83 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.42 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.96 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 7.09 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 5.81 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 96.77 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 5.16 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 70.91 | 83.88 |